[SAGE] Tocilizumab in Active, Moderate-to-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: An Open-Label Prospective Study in Two Independent Cohorts |
|
This post will be closed automatically in 2026-11-07 05:09
Reward10points
|
post
reply
points
0
10
The Struggle of Giving Up Personal Goals
100
Dynamic scheduling of human-machine collaborative flexible job shops based on deep reinforcement learning
30
Does the ※Entourage Effect§ in Cannabinoids Exist? A Narrative Scoping Review
10
Outcomes of In-Situ Reconstruction of Secondary Aorto-Enteric Fistulas
10
Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?
